Cargando…
The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration
mRNA-lipoplex vaccines are currently being explored in phase II clinical trials for the treatment of patients with advanced solid tumors. Mechanistically, these mRNA-lipoplex vaccines are characterized by the induction of type I interferon (IFN) centered innate responses. Earlier studies have identi...
Autores principales: | Van Hoecke, Lien, Roose, Kenny, Ballegeer, Marlies, Zhong, Zifu, Sanders, Niek N., De Koker, Stefaan, Saelens, Xavier, Van Lint, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533292/ https://www.ncbi.nlm.nih.gov/pubmed/33230442 http://dx.doi.org/10.1016/j.omtn.2020.09.004 |
Ejemplares similares
-
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
por: Van Hoecke, Lien, et al.
Publicado: (2018) -
In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression
por: Van den Hoecke, Silvie, et al.
Publicado: (2021) -
How mRNA therapeutics are entering the monoclonal antibody field
por: Van Hoecke, Lien, et al.
Publicado: (2019) -
Therapeutic anti-tumor immunity directed against neo-epitopes by intratumor delivery of mRNA encoding MLKL
por: Van Hoecke, Lien, et al.
Publicado: (2018) -
mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
por: Van Hoecke, Lien, et al.
Publicado: (2020)